Close

Immunogen Inc. (IMGN) Posts Q3 EPS Loss of $0.22

April 28, 2011 4:13 PM EDT
Immunogen Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $4.19 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings